Navigation Links
Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
Date:7/29/2014

Somerset, NJ (PRWEB) July 29, 2014

Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that Dr. Jeff Browne, R&D Director and US Platform Leader of Pharmaceutical Softgels, will present “Enhancing the Bioavailability of Absorption-Limited Drugs with Lipid-Based Formulations using Soft Capsule Delivery Systems” at the forthcoming 30th Annual Meeting of the Japan Society of Drug Delivery Systems (30-31 July 2014, Tokyo, Japan).

Dr. Browne’s presentation, which is a luncheon seminar on Wednesday July 30th, at 12.00 noon, will provide insight into the usefulness of lipid-based formulations to enhance absorption for drugs with limited oral bioavailability, characterized by poor solubility and/or permeability. The process of preformulation studies and prototype formulation development on a placebo lipid-based formulation will be used to demonstrate the considerations necessary before highlighting the benefits of soft capsules as a delivery method for such formulations. Catalent’s non-gelatin OptiShell™ capsule technology has successfully been used to overcome incompatibilities with gelatin-based shells, and more recently, the use of film-coated soft capsules has been investigated.

Dr. Browne’s career with Catalent started in 1994 and since then, he has held a number of positions before becoming R&D Director and US Platform Leader of Pharma Softgels. These included Executive Director & Division Head of Pharmaceutical Development in Research Triangle Park, NC, and most recently Technical Director, Pharmaceutical Softgels. He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and has served on several of their Focus Group committees. He is a frequent presenter at both regional and national AAPS meetings. Dr. Browne received his Ph.D. from Purdue University in Industrial and Physical Pharmacy.

For more information on the Japan Society of Drug Delivery Systems, visit: http://www.procomu.jp/DDS2014/index.html, and to arrange a meeting with Dr. Browne, contact Richard Kerns at richard(at)nepr(dot)eu.

About Catalent:

Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents, and in Fiscal 2013, generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2014/07/prweb12054220.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
2. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
3. Catalent Creates New Advanced Delivery Technologies Business Unit
4. Oxnard Dental Implant Experts Warn of Infections Around Dental Implants
5. Lift U.S. Ban on Blood Donations by Gay Men, Experts Say
6. Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google
7. Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood
8. New Video Release: Jason Feruggia’s Interview with Personal Trainer Marketing Expert Bedros Keuilian
9. Psoriatic arthritis patients need better screening, warns panel of experts
10. Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves
11. PoisonEXPERT™ from ExPub Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... KS (PRWEB) , ... January 18, 2017 , ... ... firm offering asset protection and financial planning services to families and business owners ... charity event aimed at supporting children with developmental disabilities. , The Lakemary Center ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that Mr. Michael Merges, Director of Strategic Growth, ... be held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, ...
(Date:1/18/2017)... Lebanon, NH (PRWEB) , ... January 18, 2017 ... ... the launch of the revolutionary Active Brake Technology (ABT), an innovative braking system ... stability. , Active Brake Technology addresses one of the biggest concerns of beginner ...
(Date:1/17/2017)... ... ... January is National Stalking Awareness Month (NSAM), now in its fourteenth year, when ... the crime of stalking, a very real danger to many in our community. We ... and other crimes. , “Stalking: know it. Name it. Stop it.”—so reads the theme for ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SHANGHAI , Jan. 18, 2017 In ... of revolution, which is where the Upgrade of ... year of the 13th Five-Year Plan for Economic and Social ... (the 13th Five-Year Plan), and the state council of ... the "13th Five-Year" national strategic emerging industry development plan, identifying ...
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology: